This firm is soliciting participants to a Phase II clinical trial with the hormonal agent toremifene for use in prostatic intraepithelial neoplasia which is thought to be a precursor condition to prostate cancer.
Prostate: Acapodene for PIN
GTx. Hormone pathways to treat cancer, bone loss, muscle wasting
2024-08-22
Business, Biotechnology and Pharmaceuticals, Pharmaceuticals, Clinical Trials - Prostate: Acapodene for PIN. This firm is soliciting participants to a Phase II clinical trial with the hormonal agent toremifene for use in prostatic intraepithelial neoplasia which is thought to be a precursor condition to prostate cancer.